Michael E. DeBakey Veterans Affairs Medical Center
Welcome,         Profile    Billing    Logout  
 36 Trials 
56 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Trautner, Barbara
NCT05261282: Mindful Hand Hygiene for Healthcare Workers

Active, not recruiting
N/A
343
US
Mindful Hand Hygiene
VA Office of Research and Development
Burnout, Mental Health
12/24
12/24
Mims, Martha
S1802, NCT03678025: Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Recruiting
3
1273
Europe, US, RoW
Abiraterone, CB 7598, Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Degarelix, FE200486, Firmagon, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Flutamide, 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid, Drogenil, Euflex, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolide, Oncosal, Profamid, Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Prostacur, Prostadirex, Prostica, Prostogenat, SCH 13521, Tafenil, Tecnoflut, Testotard, Goserelin Acetate, ZDX, Zoladex, Histrelin Acetate, Supprelin, Vantas, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Nilutamide, Anandron, Nilandron, RU-23908, Orchiectomy, Castration, Male Castration, Male Gonadectomy, orchidectomy, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisonum, Prednitone, Promifen, Servisone, SK-Prednisone, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, irradiation, Radiation, Radiotherapeutics, RADIOTHERAPY, RT, Therapy, Radiation, Radical Prostatectomy, Prostatovesiculectomy, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Decapeptyl, Detryptoreline
SWOG Cancer Research Network, National Cancer Institute (NCI)
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
04/28
10/31
TOKIN, NCT04626024: Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

Recruiting
2
100
US
Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal, Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation, Gleevec, Sprycel, Tasigna, Bosulif
Baylor College of Medicine
Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission
11/25
11/25
APRE, NCT03833921: Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

Recruiting
2
130
US
Abiraterone Acetate, Zytiga, Prednisone
Martha Mims
Prostate Cancer Metastatic, Prostate Cancer
11/24
04/34
NCT03941496: Azacytidine During Anti-tuberculosis Therapy

Withdrawn
1b/2a
50
US
Azacitidine Injection, AZA Group
Andrew Dinardo, Bristol-Myers Squibb
Tuberculosis, Pulmonary
05/23
05/23
TACTAM, NCT02291848: Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

Recruiting
1
36
US
TAA-specific CTLs, TAA-specific CTLs- fixed dose
Baylor College of Medicine, The Methodist Hospital Research Institute, Center for Cell and Gene Therapy, Baylor College of Medicine, Harris County Hospital District
Multiple Myeloma
12/24
12/27
IRONMAN, NCT03151629: International Registry for Men With Advanced Prostate Cancer

Recruiting
N/A
5000
Europe, Canada, US, RoW
Standard of Care
Prostate Cancer Clinical Trials Consortium
Prostate Cancer
01/29
01/29
Garza, Richard De La
NCT03787628: Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder

Completed
2
35
US
Cannabidiol (CBD) 600 mg, Placebo
University of California, Los Angeles, National Institute on Drug Abuse (NIDA)
Opioid-use Disorder
03/24
03/24
Villareal, Reina
NCT03887936: Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

Recruiting
4
166
US
Testosterone gel 1.62%, Androgel, Placebo
VA Office of Research and Development
Type 2 Diabetes Mellitus, Hypogonadism
09/24
09/25
Sharafkhaneh, Amir
NCT04306588: Accessing Mobility Using Wearable Sensors

Recruiting
1/2
150
US
Exercise, Tele-rehabilitation
Baylor College of Medicine, Michael E. DeBakey VA Medical Center
COPD, Pulmonary Disease, Pulmonary Restrictive Disease, Congestive Heart Failure, Cardiovascular Diseases
12/25
12/25
Bandi, Venkata
NCT04306588: Accessing Mobility Using Wearable Sensors

Recruiting
1/2
150
US
Exercise, Tele-rehabilitation
Baylor College of Medicine, Michael E. DeBakey VA Medical Center
COPD, Pulmonary Disease, Pulmonary Restrictive Disease, Congestive Heart Failure, Cardiovascular Diseases
12/25
12/25
Sandulache, Vlad
NRG-HN009, NCT05050162: Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Recruiting
2/3
464
Canada, US
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation
NRG Oncology, National Cancer Institute (NCI)
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, Advanced Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma of Unknown Primary
02/31
02/36
NRG-HN006, NCT04333537: Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Recruiting
2/3
618
Canada, US
Computed Tomography (CT), CAT, CAT scan, Computed Tomography, computerized axial tomography, Computerized Tomography, CT, CT scan, tomography, Imaging Agent, Image Enhancement Agent, Neck Dissection, Planar Imaging, Sentinel Lymph Node Biopsy, Sentinel Node Biopsy, Sentinel node biopsy alone, SLNB, SNB, Single Photon Emission Computed Tomography, Medical Imaging, Single Photon Emission Computed Tomography, Single Photon Emission Tomography, single-photon emission computed tomography, SPECT, SPECT imaging, SPECT SCAN, SPET, tomography, emission computed, single photon, Tomography, Emission-Computed, Single-Photon
NRG Oncology, National Cancer Institute (NCI)
Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma, Hard Palate Squamous Cell Carcinoma, Lip Squamous Cell Carcinoma, Lower Alveolar Ridge Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Retromolar Trigone Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8, Tongue Squamous Cell Carcinoma, Upper Alveolar Ridge Squamous Cell Carcinoma
05/31
05/36
ENDURE, NCT05793151: Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy

Recruiting
N/A
532
US
ENDURE
Medical University of South Carolina, National Cancer Institute (NCI)
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer, Oral Cavity Cancer, Larynx Cancer
03/28
03/28
Najafi, Bijan
NCT03476876: Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers

Completed
2/3
34
US
Dermacell, Dermacell acellular dermal matrix placed in one lesion, Integra, Integra bilayer cross-linked matrix placed in one lesion
Baylor College of Medicine, LifeNet Health
Diabetic Foot Ulcer, Deep Diabetic Foot Ulcer
10/20
04/21
NCT03960463: EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds

Recruiting
2/3
40
US
Transcu O2®
Baylor College of Medicine, Electrochemical Oxygen Concepts, Inc.
Surgical Wound, Diabetes, Amputation Wound, Incision Wound, Peripheral Arterial Disease, Breast Cancer, Diabetic Foot
12/24
12/24
NCT05434078: Orthofeet: A Prospective Proof of Concept Trial to Evaluate an Innovative Pain Relief Footwear

Completed
1/2
50
US
Orthofeet Shoes
Bijan Najafi, PhD, Orthofeet, Inc.
Foot Pain
08/23
08/23
NCT04307355: Continuous Diffusion of Oxygen Treatment for Incision Wounds

Recruiting
1/2
20
US
Transcu O2®
Baylor College of Medicine, Electrochemical Oxygen Concepts, Inc.
Surgical Wound, Breast Surgery, Mammoplasty, Incision Wound
12/24
12/24
NCT04306588: Accessing Mobility Using Wearable Sensors

Recruiting
1/2
150
US
Exercise, Tele-rehabilitation
Baylor College of Medicine, Michael E. DeBakey VA Medical Center
COPD, Pulmonary Disease, Pulmonary Restrictive Disease, Congestive Heart Failure, Cardiovascular Diseases
12/25
12/25
NCT06238609: Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome

Recruiting
1
40
US
Intervention Group, Control Group
Bijan Najafi, PhD, Avazzia, Inc
Muscle Atrophy, Muscle Weakness, Blood Flow
08/25
08/25
tDCS, NCT05524233: Transcranial Direct Current Stimulation

Completed
N/A
10
US
Active Transcranial Direct Stimulation
Baylor College of Medicine
Brain Fog
04/23
04/23
NCT05520008: Game-Based Foot & Ankle Exercise for Those With Lower Extremity Edema

Completed
N/A
19
US
Game-based exercise, Tele-exercise
Baylor College of Medicine, Medline Industries
Lower Extremity Swelling, Lower Extremity Edema, Venous Insufficiency of Leg
10/23
10/23
NCT06324344: Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)

Recruiting
N/A
30
US
High-Dose TENS, High Dose TENS, Active, Low-Dose TENS, Placebo
Baylor College of Medicine, NeuroMetrix, Inc.
Chemotherapy-induced Peripheral Neuropathy, Pain, Neuropathy
10/25
10/25
NCT05046158: Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care

Recruiting
N/A
200
US
Transforming Powder Dressing, Altrazeal, Standard of care topical wound agents and dressings
ULURU Inc., Naval Medical Research Center, Military Technology Enterprise Consortium (US)
Diabetic Foot Ulcer
12/23
12/23
NCT05703490: An Innovative Platform for Objective Monitoring of Instrumental Activities of Daily Living

Active, not recruiting
N/A
100
US
IADLSys system
Bijan Najafi, PhD, BioSensics
Dementia, Cognitive Impairment, Alzheimer Disease
12/24
12/24
PACS, NCT05200858: Electrical Stimulation for Post Acute COVID-19 Syndrome

Recruiting
N/A
40
US
Electrical Stimulation - Active, Electrical Stimulation - Placebo
Baylor College of Medicine, NeuroMetrix, Inc.
COVID-19, Muscle Weakness, Muscle Pain, Fatigue
12/23
12/23
Tele-foot X, NCT06439667: VIRTUALLY SUPERVISED TELE-EXERCISE PLATFORM FOR ACCELERATING PLANTAR WOUND HEALING

Not yet recruiting
N/A
15
US
Baylor College of Medicine, BioSensics
Diabetic Foot Ulcer
01/28
01/28
NCT05235113: Remote Game-based Exercise Program for Cognitive and Motor Function Improvement

Recruiting
N/A
110
US
Tele-Exergame Platform, No Tele-Exergame Platform
Baylor College of Medicine, BioSensics
Mild Cognitive Impairment, Dementia, Cognitive Impairment, Memory Loss
09/24
12/24
NCT05754021: A Practical Platform for In-Home Remote Monitoring of Cognitive Frailty

Active, not recruiting
N/A
100
US
Baylor College of Medicine, BioSensics LLC
Frailty, Cognitive Impairment, Dementia, Cognitive Impairment, Mild, Alzheimer Disease, Alzheimer Disease, Early Onset
12/24
12/24
Garcia, Jose Luis
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)

Completed
3
1403
US
Placebo, Montelukast
Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center
Covid19
07/23
01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications

Active, not recruiting
3
15000
US
Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin
Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center
Covid19
06/24
11/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)

Active, not recruiting
3
15000
US
Placebo, Metformin
Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center
Covid19
06/24
11/24
NCT06261957: A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma

Recruiting
3
412
Europe, Canada, US, RoW
Salbutamol HFA-134a, Salbutamol HFA-152a
GlaxoSmithKline
Asthma
04/25
04/25
MATINEE, NCT04133909 / 2018-001540-56: Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Calendar Jan 2024 - Dec 2024: Acceptance of regulatory submission in US (based on MATINEE trial) for COPD
Calendar Jan 2024 - Dec 2024: Acceptance of regulatory submission in EU (based on MATINEE trial) for COPD
Calendar Jan 2024 - Dec 2024: Data from MATINEE trial for COPD
Calendar Jan 2024 - Dec 2024: Acceptance of regulatory submission in China (based on MATINEE trial) for COPD
Calendar Jan 2024 - Dec 2024: Acceptance of regulatory submission in Japan (based on MATINEE trial) for COPD
Active, not recruiting
3
806
Europe, Canada, Japan, US, RoW
Placebo, Mepolizumab
GlaxoSmithKline, PPD
Pulmonary Disease, Chronic Obstructive
08/24
08/24
GRIT, NCT04867317: Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

Not yet recruiting
3
172
US
Somatropin, Placebo
VA Office of Research and Development
Adult Growth Hormone Deficiency, Mild Traumatic Brain Injury
03/26
03/28
FORMULA-OLS, NCT03583164 / 2017-001290-17: Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options

Recruiting
2b
200
Europe, US, RoW
F901318
F2G Biotech GmbH, Iqvia Pty Ltd
Invasive Fungal Infections
09/22
04/23
NCT05312567: FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms

Completed
2
105
US
FP-101
Fervent Pharmaceuticals, ICON plc
Vasomotor Symptoms, Menopause
04/23
07/23
NCT05322096: Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

Completed
2
39
Europe, US, RoW
RGH-706, Placebo
Gedeon Richter Plc.
Prader-Willi Syndrome
04/24
04/24
GWIT, NCT05355272: Growth Hormone Replacement in Veterans With GWI and AGHD

Recruiting
2
20
US
Recombinant human growth hormone, Somatropin, Genotropin, Humatrope, Norditropin
Baylor College of Medicine, United States Department of Defense
Gulf War Syndrome, Adult Growth Hormone Deficiency
05/25
09/25
TEMEC, NCT04301765: Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Recruiting
2
230
US
testosterone 1.62% gel, placebo gel
Seattle Institute for Biomedical and Clinical Research
Hypogonadism, Male, Cancer, Fatigue
01/26
01/26
NCT04049331: Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Recruiting
2
240
US
Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED], study drug, placebo
Seattle Institute for Biomedical and Clinical Research
Hypogonadism, Male, Fatigue Syndrome, Chronic
01/26
01/26
CELLO-1, NCT04179864 / 2019-003649-14: A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Checkmark Data from CELLO-1 trial for CRPC at SUO 2022
Dec 2022 - Dec 2022: Data from CELLO-1 trial for CRPC at SUO 2022
Checkmark Safety data from P1b portion of P1b/2 trial in combination with enzalutamide or with abiraterone/prednisone for CRPC at ESMO 2021
Sep 2021 - Sep 2021: Safety data from P1b portion of P1b/2 trial in combination with enzalutamide or with abiraterone/prednisone for CRPC at ESMO 2021
Active, not recruiting
1/2
102
Europe, US
Tazemetostat, EPZ-6438, E7438, IPN60200, Abiraterone/prednisone, Zytiga, Enzalutamide, Xtandi
Epizyme, Inc.
Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
09/24
09/24
PRIME CLASS, NCT05070130: OpSens

Terminated
N/A
32
Europe
dPR and FFR
Opsens, Inc.
Aortic Stenosis
03/23
04/23
NCT03867357: Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia

Active, not recruiting
N/A
60
US
GnRH agonist, Zoladex, Goserelin
Seattle Institute for Biomedical and Clinical Research, United States Department of Defense, University of Washington
Metastatic Prostate Cancer, Androgen Deprivation Therapy
09/23
08/24
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Recruiting
N/A
320
US
COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device
Piomic Medical, NAMSA
Diabetic Foot Ulcer
06/25
06/25
NCT04364256: Muscle Stimulation for Physical Function During Stem Cell Transplant

Recruiting
N/A
46
US
RS-4i Plus Sequential Stimulator (RS Medical, Vancouver, WA), NMES, e-stim
VA Office of Research and Development
Autologous Hematopoietic Stem Cell Transplant
12/25
05/26
Kosten, Thomas
NCT04360681: Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans

Recruiting
2
120
US
Lofexidine, LFX, Placebo oral tablet, PLB
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, United States Department of Defense, RTI International, Michael E. DeBakey VA Medical Center, USWM, LLC (dba US WorldMeds)
Post Traumatic Stress Disorder, Opioid-use Disorder
11/24
02/25
Bozkurt, Biykem
LINK-HF2, NCT04502563: - Remote Monitoring Analytics in Heart Failure

Recruiting
N/A
240
US
Remote monitoring and predictive analytics, Sham comparator
VA Office of Research and Development, George E. Wahlen Department of Veterans Affairs Medical Center, Michael E. DeBakey VA Medical Center, VA Palo Alto Health Care System, Malcom Randall VA Medical Center, Hunter Holmes McGuire VA Medical Center, VHA Innovation Ecosystem
Heart Failure
10/24
10/24
Lan, Charlie
NCT04306588: Accessing Mobility Using Wearable Sensors

Recruiting
1/2
150
US
Exercise, Tele-rehabilitation
Baylor College of Medicine, Michael E. DeBakey VA Medical Center
COPD, Pulmonary Disease, Pulmonary Restrictive Disease, Congestive Heart Failure, Cardiovascular Diseases
12/25
12/25
Nguyen, Christina
NCT04306588: Accessing Mobility Using Wearable Sensors

Recruiting
1/2
150
US
Exercise, Tele-rehabilitation
Baylor College of Medicine, Michael E. DeBakey VA Medical Center
COPD, Pulmonary Disease, Pulmonary Restrictive Disease, Congestive Heart Failure, Cardiovascular Diseases
12/25
12/25
Verrico, Christopher
DARP, NCT06454669: Dronabinol as an Adjunct for Reducing Pain

Recruiting
2
75
US
Dronabinol, Marinol, delta-9-tetrahydrocannabinol, Placebo
Christopher D. Verrico
Low Back Pain, Chronic Pain, Back Injuries
12/26
12/27
NCT04360681: Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans

Recruiting
2
120
US
Lofexidine, LFX, Placebo oral tablet, PLB
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, United States Department of Defense, RTI International, Michael E. DeBakey VA Medical Center, USWM, LLC (dba US WorldMeds)
Post Traumatic Stress Disorder, Opioid-use Disorder
11/24
02/25
NCT04331288: Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)

Completed
1
10
US
PT150, Formerly ORG34517, Beverage, Ethanol beverage
Pop Test Oncology LLC, Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, Congressionally Directed Medical Research Programs, Michael E. DeBakey VA Medical Center, Baylor College of Medicine
Potential Treatment for Alcohol Dependence-Alcohol Interaction
10/23
10/23
NCT06252623: Exenatide For Reducing the Reinforcing Effects of Cocaine

Recruiting
1
44
US
Exenatide, Bydureon, Placebo, saline
Christopher D. Verrico
Cocaine Use Disorder
03/26
12/26
Bryant, Monthaporn
NCT04306588: Accessing Mobility Using Wearable Sensors

Recruiting
1/2
150
US
Exercise, Tele-rehabilitation
Baylor College of Medicine, Michael E. DeBakey VA Medical Center
COPD, Pulmonary Disease, Pulmonary Restrictive Disease, Congestive Heart Failure, Cardiovascular Diseases
12/25
12/25
Shneider, Neil
REGALS, NCT05695521: Regulatory T Cells for Amyotrophic Lateral Sclerosis

Recruiting
1
66
US
CK0803, Excipient
Cellenkos, Inc.
Amyotrophic Lateral Sclerosis
05/26
12/27

Download Options